NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time
NeuroOne Medical Technologies (NASDAQ: NMTC), a medical technology company focused on improving surgical care options for neurological disorders, has scheduled its fourth quarter and fiscal year 2024 financial results release for December 17, 2024, before market open. The company will host an investor conference call and webcast at 9:00 a.m. Eastern time on the same day, featuring management discussion, corporate updates, and a Q&A session.
The earnings call will be accessible via U.S. toll-free (888-506-0062) and international (973-528-0011) dial-in numbers, with participant access code 603219. A playback will be available through December 31, 2024, and a webcast replay will be accessible until December 17, 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), una società di tecnologia medica focalizzata sul miglioramento delle opzioni di assistenza chirurgica per i disturbi neurologici, ha programmato il rilascio dei risultati finanziari del quarto trimestre e dell'anno fiscale 2024 per il 17 dicembre 2024, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast per gli investitori alle 9:00 ora orientale dello stesso giorno, comprendente una discussione della direzione, aggiornamenti aziendali e una sessione di domande e risposte.
La telefonata sugli utili sarà accessibile tramite numeri di accesso negli Stati Uniti (888-506-0062) e internazionali (973-528-0011), con il codice di accesso per i partecipanti 603219. Una registrazione sarà disponibile fino al 31 dicembre 2024, e una riproduzione del webcast sarà accessibile fino al 17 dicembre 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), una empresa de tecnología médica centrada en mejorar las opciones de atención quirúrgica para trastornos neurológicos, ha programado la publicación de sus resultados financieros del cuarto trimestre y del año fiscal 2024 para el 17 de diciembre de 2024, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica para inversores y un webcast a las 9:00 a.m. hora del Este el mismo día, que incluirá una discusión de la gestión, actualizaciones corporativas y una sesión de preguntas y respuestas.
La llamada de ganancias será accesible a través de números de marcación gratuitos en EE. UU. (888-506-0062) y números internacionales (973-528-0011), con el código de acceso para participantes 603219. Una grabación estará disponible hasta el 31 de diciembre de 2024, y una repetición del webcast será accesible hasta el 17 de diciembre de 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC)는 신경 장애에 대한 수술 치료 옵션을 개선하는 데 초점을 맞춘 의료 기술 회사로, 2024 회계년도 4분기 재무 결과 발표를 2024년 12월 17일 시장 개장 전에 예정하고 있습니다. 회사는 같은 날 동부 표준시 기준 오전 9시에 경영진 토론, 기업 업데이트 및 질의응답 세션이 포함된 투자자 컨퍼런스 콜과 웹캐스트를 주최할 것입니다.
이익 콜은 미국 무료 전화번호 (888-506-0062)와 국제 전화번호 (973-528-0011)를 통해 접근할 수 있으며, 참가자 접근 코드는 603219입니다. 재생본은 2024년 12월 31일까지 제공되며, 웹캐스트 재생본은 2025년 12월 17일까지 접근 가능합니다.
NeuroOne Medical Technologies (NASDAQ: NMTC), une entreprise de technologie médicale axée sur l'amélioration des options de soins chirurgicaux pour les troubles neurologiques, a prévu la publication de ses résultats financiers du quatrième trimestre et de l'exercice 2024 pour le 17 décembre 2024, avant l'ouverture du marché. La société organisera une conférence téléphonique pour investisseurs et un webcast à 9h00, heure de l'Est, le même jour, incluant une discussion de la direction, des mises à jour de l'entreprise et une session de questions-réponses.
La conférence téléphonique sur les bénéfices sera accessible via des numéros sans frais aux États-Unis (888-506-0062) et à l'international (973-528-0011), avec le code d'accès pour les participants 603219. Un enregistrement sera disponible jusqu'au 31 décembre 2024, et une rediffusion du webcast sera accessible jusqu'au 17 décembre 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), ein Medizintechnikunternehmen, das sich auf die Verbesserung von chirurgischen Versorgungsoptionen für neurologische Störungen konzentriert, hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 für den 17. Dezember 2024, vor Markteröffnung, angesetzt. Das Unternehmen wird am selben Tag um 9:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast für Investoren veranstalten, in dem die Unternehmensführung diskutiert, Unternehmensupdates gegeben werden und eine Frage-Antwort-Runde stattfindet.
Der Gewinnanruf wird über die gebührenfreie US-Nummer (888-506-0062) sowie internationale Nummern (973-528-0011) zugänglich sein, mit dem Zugangscode 603219 für Teilnehmer. Eine Aufnahme wird bis zum 31. Dezember 2024 verfügbar sein, und eine Webcast-Wiedergabe wird bis zum 17. Dezember 2025 zugänglich sein.
- None.
- None.
EDEN PRAIRIE, Minn., Dec. 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for the fiscal fourth quarter and year ended September 30, 2024, before market open on December 17, 2024.
Management will host an investor conference call and webcast at 9:00 a.m. Eastern time on Tuesday, December 17, 2024 to discuss the Company’s fourth quarter and fiscal year 2024 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following infomaiton:
Fourth Quarter and Fiscal 2024 Earnings Conference Call
Date: Tuesday, December 17, 2024
Time: 9:00 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 603219
Webcast: NMTC Fourth Quarter and Fiscal 2024 Earnings Conference Call
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through December 31, 2024. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 51728. A webcast replay will also be available using the webcast link above through December 17, 2025.
About NeuroOne
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us
FAQ
When will NeuroOne (NMTC) release its Q4 and fiscal year 2024 earnings?
How can investors join NeuroOne's (NMTC) Q4 2024 earnings call?
Until when will NeuroOne's (NMTC) Q4 2024 earnings call replay be available?
